News and Announcements
Altech Sells Exploration Licence for $2.0 Million Cash
- Published May 10, 2016 11:42AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
9th May 2016, ASX Announcement
Highlights:
- Sale of surplus exploration license for $2 million
- Dispute over termination of Kaolin Mining Rights Deed with Dana settled
- Altech retains ownership of mining lease application M70/1334 for its Malaysian HPA project
- Imminent grant of M70/1334
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to announce that it has executed an agreement with Dana Shipping and Trading S.A. (Dana) for the sale of exploration license E70/3923 (excluding mining lease application M70/1334, owned by Altech) at Meckering, Western Australia for $2.0 million.
The exploration licence is surplus to Altech’s feedstock requirements for its proposed Malaysian high purity alumina (HPA) plant. Feedstock for the plant will be sources from within M70/1334 which contains estimated ~11 million tonnes of kaolin mineral resources, representing in excess of 250 years of supply for the HPA plant.
To view the full announcement please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
